13578_2019_326_MOESM1_ESM.pdf (650.06 kB)
MOESM1 of miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients
journal contribution
posted on 2019-08-08, 04:21 authored by Carlos Rodríguez-Antolín, Laura Felguera-Selas, Olga Pernía, Olga Vera, Isabel Esteban, Itsaso Losantos García, Javier de Castro, Rocío Rosas-Alonso, Inmaculada Ibanez de CaceresAdditional file 1. Figure S1. Example of methylated and unmethylated amplification by qMSP. Figure S2. Kaplan-Meier survival curves for advanced-stage NSCLC in relation to miR-7 methylation.